September 27, 2023 – About 250,000 doses of Pfizer’s anti-COVID pills will probably be administered weekly, CEO Albert Bourla said this week.
The oral antiviral drug Paxlovid is being distributed freed from charge by the US government. The government has purchased about 24 million doses. According to the US Department of Health and Human Services, about 15 million doses have been distributed to date, Reuters reported.
Bourla said it is just not yet clear when Paxlovid will receive approval on the market within the U.S. market. Reuters reported.
He said the corporate was “ready to bring its COVID-19 vaccines to the commercial market smoothly,” Reuters reported.
“There is already enough product and we are continuing to produce,” said Bourla. “We are very confident that the market will be very well supplied.”
Paxlovid – given for five days starting shortly after symptoms begin – is used to treat adults who’re at higher risk of being hospitalized or dying from COVID-19.
Reuters reported “problems” with the rollout of the brand new, updated COVID-19 vaccines, with some people saying they were told by pharmacies that they didn’t have the needed vaccines in stock.
Bourla spoke at Cantor Fitzgerald's annual healthcare conference.